Showing results (61-70 of 2,068) with videos related to
Sort By:
Pageof 207
Clinical Chemistry|January 1, 1989
Increased concentrations of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin IIIJ Gram, J JespersenActa Radiologica (Stockholm, Sweden : 1987)|September 1, 1995
Colo-colonic intussusception caused by lipoma. Case reportsC Wulff, N JespersenThrombosis and Haemostasis|June 30, 1986
Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycleJ Jespersen, C KluftFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1984
Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysisT Astrup, J JespersenScandinavian Journal of Primary Health Care|May 1, 1984
Lay concepts and strategies for handling symptoms of disease. A sample of adult men and women experiencing back pain symptomsD Gannik, M JespersenMetabolism: Clinical and Experimental|May 1, 1992
Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patientsJ Gram, J JespersenThrombosis and Haemostasis|August 30, 1985
Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivatorJ Jespersen, C KluftThrombosis and Haemostasis|April 22, 1985
A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samplesJ Gram, J JespersenInternational Journal of Mental Health Nursing|January 24, 2008
Side-effects and treatment with clozapine: a comparison between the views of consumers and their cliniciansKay Hodge, Sean JespersenInternational Journal of Food Microbiology|November 1, 1996
Specific spoilage organisms in breweries and laboratory media for their detectionL Jespersen, M JakobsenPageof 207